United States · Series A startup

Who invested in StimCardio

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechMedical DevicesWearables

Raised this month

Funding summaryUpdated 31 Oct 2026

$30Mraised across 1 round since 2026, from 2 sources

Latest round
Series A, $30MOct 2026
Led by
Metis Medtech
Investors
2 (1 led)
See who backed them

The rounds

  1. Oct 2026
    Series A$30M

    Reported by Google News search and 1 other

Everyone who backed them

Metis MedtechVC firm1round, led 1

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list StimCardio as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

New York AngelsAngel networkPer its own site
NeoPrima VenturesVC firmPer its own site

Quick answers about StimCardio

Who invested in StimCardio?

StimCardio's investors include Metis Medtech and Catalyst Health Ventures. Metis Medtech led its latest round.

How much has StimCardio raised?

StimCardio has raised $30M across 1 round since 2026.

When did StimCardio last raise?

StimCardio's most recent round was a Series A of $30M in Oct 2026, led by Metis Medtech.

What was StimCardio's biggest round?

Its most recent round, $30M in Oct 2026, is also its largest on record.

Who backed StimCardio first?

StimCardio's first round on record, in Oct 2026, was backed by Metis Medtech and Catalyst Health Ventures.

What stage is StimCardio at?

StimCardio's latest named round is a Series A, in Oct 2026.

Where is StimCardio based?

StimCardio is based in the United States.

Who led StimCardio's rounds?

Metis Medtech led the Series A in 2026.

Companies like StimCardio

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.